These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26546114)

  • 41. Glucose Controls the Expression of Polypyrimidine Tract-Binding Protein 1 via the Insulin Receptor Signaling Pathway in Pancreatic β Cells.
    Jeong DE; Heo S; Han JH; Lee EY; Kulkarni RN; Kim W
    Mol Cells; 2018 Oct; 41(10):909-916. PubMed ID: 30165730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two different vestigial like 4 genes are differentially expressed during Xenopus laevis development.
    Barrionuevo MG; Aybar MJ; Tríbulo C
    Int J Dev Biol; 2014; 58(5):369-77. PubMed ID: 25354458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryonic frog epidermis: a model for the study of cell-cell interactions in the development of mucociliary disease.
    Dubaissi E; Papalopulu N
    Dis Model Mech; 2011 Mar; 4(2):179-92. PubMed ID: 21183475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic loss of function of Ptbp1 does not induce glia-to-neuron conversion in retina.
    Hoang T; Kim DW; Appel H; Pannullo NA; Leavey P; Ozawa M; Zheng S; Yu M; Peachey NS; Blackshaw S
    Cell Rep; 2022 Jun; 39(11):110849. PubMed ID: 35705053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma.
    Kaya B; Goceri E; Becker A; Elder B; Puduvalli V; Winter J; Gurcan M; Otero JJ
    PLoS One; 2017; 12(3):e0170991. PubMed ID: 28282372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA.
    Cibois M; Gautier-Courteille C; Vallée A; Paillard L
    RNA; 2010 Jan; 16(1):10-5. PubMed ID: 19933768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel ciliogenesis factors using a new in vivo model for mucociliary epithelial development.
    Hayes JM; Kim SK; Abitua PB; Park TJ; Herrington ER; Kitayama A; Grow MW; Ueno N; Wallingford JB
    Dev Biol; 2007 Dec; 312(1):115-30. PubMed ID: 17961536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radial intercalation of ciliated cells during Xenopus skin development.
    Stubbs JL; Davidson L; Keller R; Kintner C
    Development; 2006 Jul; 133(13):2507-15. PubMed ID: 16728476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morpholinos Do Not Elicit an Innate Immune Response during Early Xenopus Embryogenesis.
    Paraiso KD; Blitz IL; Zhou JJ; Cho KWY
    Dev Cell; 2019 May; 49(4):643-650.e3. PubMed ID: 31112700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Desmoplakin is required for epidermal integrity and morphogenesis in the Xenopus laevis embryo.
    Bharathan NK; Dickinson AJG
    Dev Biol; 2019 Jun; 450(2):115-131. PubMed ID: 30935896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels.
    Müller JS; Burns DT; Griffin H; Wells GR; Zendah RA; Munro B; Schneider C; Horvath R
    Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32527837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-transcriptional regulation in Xenopus embryos: role and targets of EDEN-BP.
    Osborne HB; Gautier-Courteille C; Graindorge A; Barreau C; Audic Y; Thuret R; Pollet N; Paillard L
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1541-3. PubMed ID: 16246165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.
    Santiago JA; Potashkin JA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2257-62. PubMed ID: 25646437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study.
    Gardeux V; Arslan AD; Achour I; Ho TT; Beck WT; Lussier YA
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S1. PubMed ID: 25079003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Innate Immune Response and Off-Target Mis-splicing Are Common Morpholino-Induced Side Effects in Xenopus.
    Gentsch GE; Spruce T; Monteiro RS; Owens NDL; Martin SR; Smith JC
    Dev Cell; 2018 Mar; 44(5):597-610.e10. PubMed ID: 29478923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanded PCH1D phenotype linked to EXOSC9 mutation.
    Bizzari S; Hamzeh AR; Mohamed M; Al-Ali MT; Bastaki F
    Eur J Med Genet; 2020 Jan; 63(1):103622. PubMed ID: 30690203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SINEUP long non-coding RNA acts via PTBP1 and HNRNPK to promote translational initiation assemblies.
    Toki N; Takahashi H; Sharma H; Valentine MNZ; Rahman FM; Zucchelli S; Gustincich S; Carninci P
    Nucleic Acids Res; 2020 Nov; 48(20):11626-11644. PubMed ID: 33130894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.
    Ziegler N; Cortés-López M; Alt F; Sprang M; Ustjanzew A; Lehmann N; El Malki K; Wingerter A; Russo A; Beck O; Attig S; Roth L; König J; Paret C; Faber J
    Oncoimmunology; 2023; 12(1):2184143. PubMed ID: 36875548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.
    Zhou H; Su J; Hu X; Zhou C; Li H; Chen Z; Xiao Q; Wang B; Wu W; Sun Y; Zhou Y; Tang C; Liu F; Wang L; Feng C; Liu M; Li S; Zhang Y; Xu H; Yao H; Shi L; Yang H
    Cell; 2020 Apr; 181(3):590-603.e16. PubMed ID: 32272060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-transcriptional control of cellular differentiation by the RNA exosome complex.
    Fraga de Andrade I; Mehta C; Bresnick EH
    Nucleic Acids Res; 2020 Dec; 48(21):11913-11928. PubMed ID: 33119769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.